On November 3, the FDA will host an unprecedented discussion between the diabetes community and its senior agency leadership (both drugs and devices). The event will be live webcasted from 1 – 4 pm, and will include a panel of people with type 1 and type 2 diabetes, as well as representatives from ADA, JDRF, and diaTribe.